Patent · US Active

Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology

US10285935B2 · kind B2 · utility

0Cited by
4References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 20, 2016
Grant dateMay 14, 2019
Priority date
Expiry dateDec 20, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2025/1052
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Most spinal cord therapies are administered systemically, with only a small portion of the therapeutic reaching the spinal cord. A novel method for delivering therapeutics directly to the spinal cord is provided. The method uses a dual balloon catheter to isolate the microvasculature around a region of the spinal cord. Once isolated, one or more therapeutics are delivered directly to the spinal cord blood supply. This allows for smaller, safer therapeutic dose to be utilized.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.